Business
BioSpectrum Asia
New vaccine set for human trials in Nipah outbreak hotspot
A promising vaccine candidate against one of the world's most deadly viruses, Nipah, is ready for testing in mid-stage human trials in Bangladesh, where people now die almost every year in Nipah disease outbreaks.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
IHH Healthcare catalyses clinical research across global network with initial S$5 M fund
Malaysia headquartered IHH Healthcare, a world-leading integrated healthcare provider, has launched a transformative S$5 million (~Rs 34 crore) Research Grant & Innovation Sandbox programme to accelerate clinical research and innovation across its global network.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
APAC building on enough supply network for radiopharmaceuticals
The radiopharmaceutical industry is gaining ground across the Asia-Pacific (APAC) region, as countries not only step up development of novel therapies but also move to secure critical supply chains. From new partnerships to domestic isotope production, let's explore how APAC is building a foothold in this specialised sector.
4 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
The Future Formula: What's Driving Recruitment Innovation in Pharma
The pharmaceutical recruitment process is becoming more organised, strategic, and data-driven, adapting to changing demands and needs.
5 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Restore Medical secures $23 M to advance medical device for heart failure therapy
Restore Medical, a clinical-stage medtech startup based in Israel, developing transcatheter therapies for heart failure, has announced the successful closing of a $23 million Series B financing round.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
PAHO launches dashboard to monitor respiratory viruses in the Americas
The Pan American Health Organization (PAHO) has launched a new interactive dashboard to enhance monitoring and analysis of respiratory virus circulation trends across the Americas, with the goal of strengthening surveillance and facilitating timely analysis of regional trends.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
HanchorBio signs $200 M deal with Shanghai Henlius Biotech to expand immuno-oncology reach
HanchorBio Inc., a Taiwan-based biotechnology startup developing innovative immunotherapies for oncology and autoimmune diseases, has announced the signing of a major out-licensing agreement with Shanghai Henlius Biotech, Inc.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Resurging Funding Catapults APAC BIOTECH STARTUPS
Asia-Pacific's biotech startup scene is on the cusp of a renaissance. After a tough 2024 marked by shrinking venture capital, 2025 is showing revived investor enthusiasm and a rebound in funding- especially for oncology, gene therapy, and AI-driven drug discovery. With 9,905 life sciences startups now active across the region, APAC Countries are leveraging scientific innovation, government support, and new incubators to move beyond service roles and develop world-class therapeutic assets. Let's take a closer look at Asia's startup ecosystem, evolution of investor sentiment over the past few years, and buoying biotech areas.
10 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
WHO maps application of AI in traditional medicine
In a significant milestone for global healthcare innovation, the World Health Organization (WHO) has released a technical brief titled \"Mapping the Application of Artificial Intelligence in Traditional Medicine\", acknowledging India’s pioneering efforts in integrating Artificial Intelligence (AI) with traditional medicine systems, particularly Ayush systems.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Thermo Fisher introduces new assay to help advance future of precision medicine
US-based Thermo Fisher Scientific has announced that the Oncomine Comprehensive Assay Plus is now available on the Ion Torrent Genexus System helping accelerate precision oncology research.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Agilent launches InfinityLab Pro iQ Series Mass Detectors in India
Agilent Technologies has launched its InfinityLab Pro iQ Series mass detectors in India.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Chugai and Gero ink $250 M deal to develop new therapies for age-related diseases
Japan's Chugai Pharmaceutical and Gero, a Singaporebased biotechnology company, have entered into a joint research and license agreement to develop novel therapies for age-related diseases.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Emergency vaccine response cuts infectious disease deaths by nearly 60%
Researchers at Burnet Institute, in collaboration with Gavi, the Vaccine Alliance, have provided the world's first ever look at the historical impact of emergency vaccination efforts on public health and global health security, with a comprehensive study of 210 outbreaks of five infectious diseases- cholera, ebola, measles, meningitis and yellow fever, in 49 lower-income countries between 2000 and 2023.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
“We plan to enter India, Japan, Thailand, and Vietnam to improve the safety of researchers”
As biotech research laboratories, in both industry and academic settings, engage in increasingly complex projects worldwide, ensuring the safety of personnel, equipment, and the surrounding environment becomes paramount.
4 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
JCR Pharma licenses gene therapy platform to AstraZeneca Rare Disease unit for $825 M
Japan's JCR Pharmaceuticals has entered into a license agreement with Alexion, AstraZeneca Rare Disease, for JCR's new, proprietary JUST-AAV capsids to develop genomic medicines.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Hong Kong launches generelated therapy trials to eradicate chronic hepatitis B infection
Researchers in gastroenterology and hepatology at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have initiated multiple clinical trials exploring pioneering generelated therapy for chronic hepatitis B infection, potentially allowing patients to discontinue long-term medication.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Wuxi Biologics launches next-generation platform for high-concentration biologics
Wuxi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO) in China, has announced the launch of WuXiHigh 2.0, a high-throughput formulation development platform designed for high concentration biologics.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Hyphens Pharma introduces acne treatment 'Winlevi' in Singapore and Malaysia
Hyphens Pharma, a subsidiary of Hyphens Pharma International Limited, Singapore's leading specialty pharmaceutical and consumer healthcare group, has announced the launch of Winlevi (clascoterone) cream 1 per cent in Singapore and Malaysia, marking its first entry into Southeast Asia.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Biotech’s Resurgence: Innovation Amid Market Disruption or A Generational Opportunity in Innovation
The biotechnology sector is showing signs of a resurgence.
3 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
China's Innovative Approach to Universal Health Coverage
China has successfully implemented various medical insurance reforms and development tasks under five principles including promoting equity and accessibility, the rule of law, technological empowerment, coordinated development and safeguarding the security of the fund during the first four years of the 14th Five-Year Plan (the 2021-2025 period).
2 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
M42 and GE HealthCare join forces to advance AI-enabled solutions in UAE
M42, a global health leader powered by technology, artificial intelligence (AI) and genomics, will collaborate with GE HealthCare, a global innovator in medical technology, pharmaceutical diagnostics and integrated, cloud-first AI-enabled digital solutions, to enhance diagnostic precision and deliver more personalised patient outcomes, marking a significant step forward in the future of smart AI healthcare in the UAE.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Singapore pledges contribution of $1 M to Gavi for better access to vaccines
The Singapore government has pledged a contribution of $1 million to Gavi, the Vaccine Alliance.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
"HSA is adopting a forward-looking 5P Strategy to tackle challenges"
Adjunct Professor (Dr) Raymond Chua, who stepped into his role as CEO of Singapore's Health Sciences Authority (HSA) in December 2024, outlines the agency's current priorities in positioning Singapore as a regional hub for biotech and medtech innovation.
6 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Japan engineers functional liver organoids with organspecific vasculature
Liver organoids with proper blood vessel networks have been successfully produced, as reported by researchers from Institute of Science Tokyo, Japan and Cincinnati Children's Hospital Medical Center in the US.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Singapore pilots innovative approach to diabetic foot care through 3D-printed custom insoles
Sengkang General Hospital (SKH) has piloted an innovative approach to diabetic foot care through in-house production of 3D-printed custom insoles in a cross-institution collaboration with Singapore General Hospital's (SGH) 3D printing centre.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Korea supports international patients through medical sharing programme
The Korea International Medical Association, represented by Chairman Young Tae Kim, has signed a Memorandum of Understanding, with the Korea Health Industry Development Institute, led by President Soon Do Cha, and GS Retail, represented by CEO Seo Hong Heo.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
DeepTek AI solution gains WHO recommendation in global fight against TB
Indian startup DeepTek, a leading medical imaging AI company, has received a significant recommendation from the World Health Organization (WHO) for its Chest X-ray AI solution for TB screening.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Novo Nordisk invests RMB 800 M to expand manufacturing plant in China
Novo Nordisk has signed a Memorandum of Understanding (MoU) with TEDA Administrative Commission, agreeing to invest approximately RMB 800 million in the expansion of quality testing laboratories at its Tianjin manufacturing plant.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Australia develops new ultrasound imaging device to map drug delivery into brain
A new device combining ultrasound and advanced imaging to provide crucial information for the safe delivery of drugs into the brain has been developed by University of Queensland researchers in Australia.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
“UK-India Free Trade Agreement helps deepen Genomics Collaboration”
Oxford Nanopore Technologies, a global company with its headquarters in the United Kingdom, has signed Letters of Intent with India's Centre for DNA Fingerprinting and Diagnostics (CDFD), and the National Institute of Biomedical Genomics (NIBMG), to develop two new genomic Centres of Excellence Institutes.
5 min |